GNH INDIA Mumbai, Maharashtra

• MOQ 2 Box
• FormInsulin Injection
• Packaging TypeBox
• Storageroom temperature (below 30˚C) or in a refrigerator (2˚C to 8˚C)
• Medicine TypeInsulin Injection
• Brand NameSaxenda,Saxenda,Saxenda
• Material6 mg of liraglutide
• ApplicationWeight Loss and Chronic Obesity
• Feature6 mg of liraglutide
• CertificateFDA
• TypeInsulin Injection,Saxenda Liraglutide,Saxenda Liraglutide
• Properties6 mg of liraglutide
• Warranty24 Month
• Country of OriginUSA,USA
• ManufacturerNovo Nordisk
• Size6 mg / 3ml

Saxenda ® is an injectable medicine used for adults with excess weight who may also have weight-related medical problems or obesity and children aged 12-17 years old. Novo Nordisk . Saxenda is approved by the US FDA for the treatment of chronic weight management. Credit: Novo Nordisk. Saxenda contains an active ingredient called liraglutide, which is a glucagon-like peptide-1 (GLP-1) analogue.

• MOQ 2 Box
• Brand NameMounjaro Zepbound,Zepbound Mounjaro,Zepbound Mounjaro
• ColorTranslucent
• FormInjectable Liquid
• Dosage Form2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
• UsageChronic WEIGHT Loss and OBESITY
• Purity100
• FeatureTirzepatide 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
• Packaging TypeBox
• Packaging Size1ml
• API FormLiquid
• TypeInsulin Injection,Insulin Injection,Insulin Injection
• Shelf Life24 Months
• Strength2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
• TreatmentChronic WEIGHT Loss and OBESITY
• CompositionTirzepatide Tirzepatide 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
• Country of OriginMade In India,USA
• DosageTirzepatide 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
• StorageAt room temperature (below 30˚C) or in a refrigerator (2˚C to 8˚C)
• Available Dose2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
• Generic NameZepbound Mounjaro
• Minimum Order Quantity2
• Manufacturer ByEli Lilly and Company
• Therapeutic UsesChronic WEIGHT Loss and OBESITY
• Company NameEli Lilly and Company
• Directions For UseUnder the Skin
• Prescription/Non PrescriptionNon Prescription
• Manufactured ByEli Lilly and Company
• Drug Strength2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
• ManufacturerEli Lilly and Company
• Deals inInsulin Injections
• Usage/ApplicationChronic WEIGHT Loss and OBESITY
• Warranty24 Months
• Size2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg

Tirzepatide , a  GIP /GLP-1R unimolecular dual agonist, regulates metabolism via both peripheral organs and the central nervous system. Medication: Tirzepatide Tirzepatide, sold under the brand name Mounjaro among others, is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections. AHFS/Drugs.com: Monograph ATC code: A10BX16 (WHO) QA10BX16 (WHO) Bioavailability: 80% Elimination half-life: 5 days Excretion: Urine and faeces License data: US DailyMed: Tirzepatide Metabolism: Proteolytic cleavage, β-oxidation of fatty diacid section and amide hydrolysis. Tirzepatide Neuropeptide Analogue of Gastric Inhibitory Polypeptide Tirzepatide, sold under the brand name Mounjaro among others, is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections (under the skin).